GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

HLB Therapeutics Co 115450.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

2,740

+13.93%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩69.56bn

FY2016FY2025

Net income

−₩9.23bn

FY2016FY2025

Free cash flow

−₩18.24bn

FY2016FY2025

Shareholders' equity

₩150.25bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩69.56bn₩54.93bn₩52.59bn₩48.13bn₩43.59bn₩42.93bn₩58.97bn₩43.58bn₩17.15bn₩17.71bn
Research and development———₩63.4m———₩10.8m₩1.13bn₩1.13bn
Operating income−₩3.53bn−₩21.95bn−₩8.04bn−₩8.33bn−₩11.09bn−₩11.27bn−₩10.92bn₩5.61bn−₩4.61bn−₩5.07bn
Net income−₩9.23bn−₩22.79bn−₩2.30bn−₩11.35bn−₩17.20bn−₩16.90bn−₩16.42bn₩4.57bn−₩4.82bn−₩5.20bn
Diluted earnings per share-104.66-272.18-30.48-179.22-267.77-634.46-664.87189.18-210.97-243.74

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩228.66bn₩219.79bn₩200.79bn₩187.64bn₩189.71bn₩121.94bn₩139.52bn₩107.66bn₩62.71bn₩51.65bn
Cash and short-term investments—₩37.77bn₩32.35bn₩63.95bn₩100.51bn₩28.79bn₩48.15bn₩16.85bn₩5.91bn₩4.58bn
Total liabilities₩54.79bn₩62.33bn₩29.28bn₩70.94bn₩71.03bn₩32.58bn₩75.58bn₩38.99bn₩24.27bn₩17.77bn
Debt₩25.36bn₩23.35bn₩10.02bn₩52.13bn₩51.13bn₩13.33bn₩48.77bn₩8.85bn₩14.12bn₩10.30bn
Shareholders' equity₩150.25bn₩157.46bn₩160.47bn₩116.71bn₩118.68bn₩89.35bn₩63.94bn₩68.66bn₩38.44bn₩33.88bn
Shares outstanding88m84m76m63m64m27m25m24m23m21m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩8.18bn₩1.29bn₩3.33bn−₩8.81bn−₩11.27bn−₩11.65bn−₩5.54bn−₩3.53bn−₩4.66bn−₩2.72bn
Capital spending−₩10.07bn−₩8.74bn−₩5.76bn−₩3.40bn−₩822.9m−₩85.5m−₩555.6m−₩222.7m−₩188.9m−₩10.81bn
Free cash flow−₩18.24bn−₩7.45bn−₩2.43bn−₩12.20bn−₩12.09bn−₩11.74bn−₩6.10bn−₩3.75bn−₩4.85bn−₩13.53bn
Dividends paid——————−₩46.6m−₩24.3m−₩77.7m−₩123.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩12.56bn₩13.05bn₩22.78bn₩16.06bn₩15.67bn₩15.05bn₩16.46bn₩14.05bn
Operating income—−₩4.04bn₩4.09bn−₩5.38bn−₩665.8m−₩3.13bn₩2.04bn−₩970.3m
Net income−₩8.87bn−₩4.32bn₩642.7m−₩5.48bn₩66.7m−₩4.46bn₩1.88bn−₩2.56bn
Diluted earnings per share-100.57-49.007.29-62.160.76-53.2322.43-30.58
Cash from operations−₩3.14bn−₩2.66bn₩1.10bn₩820.0m−₩5.91bn−₩4.19bn₩1.29bn−₩14.11bn
Capital spending−₩1.95bn−₩733.0m−₩819.0m−₩3.90bn−₩2.86bn−₩2.48bn−₩8.73bn−₩6.38bn
Free cash flow−₩5.10bn−₩3.39bn₩279.0m−₩3.08bn−₩8.77bn−₩6.66bn−₩7.45bn−₩20.49bn
Total assets₩220.71bn₩229.36bn₩228.66bn₩227.44bn₩211.33bn₩224.48bn₩219.79bn₩204.18bn
Cash and short-term investments—————₩29.67bn₩37.77bn₩29.95bn
Debt—₩15.94bn₩25.36bn₩9.44bn₩4.47bn₩10.61bn₩5.37bn₩17.45bn
Shareholders' equity₩144.01bn₩151.25bn₩150.25bn₩146.48bn₩150.72bn₩153.62bn₩157.46bn₩146.68bn

Financial ratios

Data as of 3 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015FY2014
Operating margin-5.1%-40.0%-15.3%-17.3%-25.4%-26.2%—————
Net margin-13.3%-41.5%-4.4%-23.6%-39.5%-39.4%—————
Return on equity-6.1%-14.5%-1.4%-9.7%-14.5%-18.9%—————
Return on assets-4.0%-10.4%-1.1%-6.1%-9.1%-13.9%—————
Free cash flow yield——————-6.4%-9.2%———
Revenue growth26.6%4.5%9.3%10.4%1.5%-27.2%—————
Earnings growth-59.5%890.1%-79.7%-34.0%1.7%2.9%—————
Current ratio2.84x1.70x1.86x1.36x2.00x2.06x—————
Debt to equity0.17x0.03x0.01x0.02x0.00x0.00x—————
Equity ratio65.7%71.6%79.9%62.2%62.6%73.3%—————
Interest coverage-1.84x-11.17x-7.23x-1.56x-9.55x-2.65x—————
R&D as a share of sales———0.1%——0.0%6.6%6.4%2.4%4.5%
Buybacks as a share of market value——————-5.9%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.1%10.1%15.3%
Operating income-24.9%-20.7%1.1%
Net income-6.7%-11.4%7.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-20.5%-18.6%-20.6%-17.7%
Net margin-25.7%-20.3%-25.6%-22.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-27.3-39.0-130.5-27.4-22.4-19.5-19.963.1-70.6-28.9
Price to sales3.616.25.76.58.87.75.56.619.88.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 21-for-20 split · 12 Mar 2026
  • 21-for-20 split · 14 Jan 2025
  • 207-for-200 split · 27 Dec 2023
  • 2-for-1 split · 15 Mar 2023
  • 207-for-200 split · 28 Dec 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.